ID   UT-SCV-2
AC   CVCL_6469
SY   University of Turku-Squamous cell Carcinoma of the Vulva-2
DR   IARC_TP53; 21683
DR   Wikidata; Q54992195
RX   PubMed=9887230;
RX   PubMed=15047230;
CC   Doubling time: 56 hours (PubMed=15047230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   PubMed=9887230; DOI=10.1006/gyno.1998.5194;
RA   Rantanen V., Grenman S.E., Kurvinen K., Hietanen S.H., Raitanen M.,
RA   Syrjanen S.M.;
RT   "p53 mutations and presence of HPV DNA do not correlate with
RT   radiosensitivity of gynecological cancer cell lines.";
RL   Gynecol. Oncol. 71:352-358(1998).
//
RX   PubMed=15047230; DOI=10.1016/j.ygyno.2003.12.033;
RA   Raitanen M., Worsham M.J., Lakkala T., Carey T.E., Van Dyke D.L.,
RA   Grenman R., Klemi P., Rantanen V., Isola J.J., Grenman S.E.;
RT   "Characterization of 10 vulvar carcinoma cell lines by karyotyping,
RT   comparative genomic hybridization and flow cytometry.";
RL   Gynecol. Oncol. 93:155-163(2004).
//